SFM
Sphera Funds Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-288,000
| Closed | -$4.46M | – | 114 |
|
|
2024
Q2 | $4.46M | Hold |
288,000
| – | – | 0.61% | 47 |
|
|
2024
Q1 | $4.59M | Buy |
+288,000
| New | +$4.59M | 0.65% | 50 |
|
|
2020
Q3 | – | Sell |
-730,557
| Closed | -$3.38M | – | 95 |
|
|
2020
Q2 | $3.38M | Buy |
+730,557
| New | +$3.38M | 0.32% | 55 |
|
|
2018
Q1 | – | Sell |
-576,825
| Closed | -$2.26M | – | 113 |
|
|
2017
Q4 | $2.26M | Buy |
+576,825
| New | +$2.26M | 0.26% | 83 |
|
|
2016
Q2 | – | Sell |
-905,000
| Closed | -$1.06M | – | 90 |
|
|
2016
Q1 | $1.06M | Sell |
905,000
-550,000
| -38% | -$644K | 0.23% | 73 |
|
|
2015
Q4 | $3.57M | Buy |
1,455,000
+355,000
| +32% | +$870K | 0.52% | 36 |
|
|
2015
Q3 | $3.3M | Sell |
1,100,000
-100,000
| -8% | -$300K | 0.42% | 41 |
|
|
2015
Q2 | $4.96M | Buy |
1,200,000
+100,000
| +9% | +$413K | 0.49% | 39 |
|
|
2015
Q1 | $4.76M | Buy |
1,100,000
+40,000
| +4% | +$173K | 0.5% | 40 |
|
|
2014
Q4 | $3.15M | Buy |
1,060,000
+374,500
| +55% | +$1.11M | 0.54% | 56 |
|
|
2014
Q3 | $2.28M | Buy |
+685,500
| New | +$2.28M | 0.28% | 68 |
|